Dr. Bill Chin - Clinical Diversity

Gary Puckrein - DIVERSITY

Millicent Gorham at #PhRMA14

Ho Luong Tran - DIVERSITY

Select a Contributor Response

Conversations:

What steps can we take to increase patient participation in clinical trials, particularly among diverse populations?

View All Conversations

 

What steps can we take to increase patient participation in clinical trials, particularly among diverse populations?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Averl Anderson
,


Gary Puckrein
,


Ho Luong Tran
,


Select a Contributor Response

Conversations:

What would the recent proposed changes to Medicare Part D’s six protected classes mean for patients?

View All Conversations

 

What would the recent proposed changes to Medicare Part D’s six protected classes mean for patients?

Test Name
Test Title, Test Company

Read biography×
This is a test modal

Mary Grealy - Part D

Submitted by Julie on

When we look at the Medicare Part D prescription drug program as a whole, we see that it is unquestionably making a positive difference in the lives of the millions of seniors and beneficiaries with disabilities who depend on it.  Enrollees have affordable plans and medications and those with severe health conditions have the guarantees that they will have access to the drugs they and their physicians have determined they need.

Pages

Subscribe to PhRMA RSS